Alvotech Files Form 6-K with SEC
Ticker: ALVOW · Form: 6-K · Filed: Jul 9, 2025 · CIK: 1898416
| Field | Detail |
|---|---|
| Company | Alvotech (ALVOW) |
| Form Type | 6-K |
| Filed Date | Jul 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, regulatory
TL;DR
Alvotech filed a 6-K on 7/9/25, confirming 20-F annual reports. Standard procedure.
AI Summary
Alvotech, a biopharmaceutical company, filed a Form 6-K on July 9, 2025. The filing is a report of a foreign private issuer and indicates that Alvotech files annual reports under Form 20-F. The company's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg.
Why It Matters
This filing confirms Alvotech's reporting status as a foreign private issuer and its adherence to SEC regulations for annual reporting.
Risk Assessment
Risk Level: low — This filing is a routine procedural report and does not contain new financial or operational information that would typically impact risk.
Key Players & Entities
- Alvotech (company) — Registrant
- 001-41421 (company) — SEC File Number
- 9, Rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg (company) — Principal executive office address
- July 9, 2025 (date) — Filing date
FAQ
What type of filing is this Form 6-K?
This Form 6-K is a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934.
What is Alvotech's SEC file number?
Alvotech's SEC file number is 001-41421.
Does Alvotech file annual reports under Form 20-F?
Yes, Alvotech indicates by check mark that it files annual reports under cover of Form 20-F.
Where is Alvotech's principal executive office located?
Alvotech's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg.
What is the filing date of this Form 6-K?
This Form 6-K was filed on July 9, 2025.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 9, 2025 regarding Alvotech (ALVOW).